These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

634 related items for PubMed ID: 18384577

  • 21. Hypertrophic cardiomyopathy: risk factors for life and living benefits insurance.
    Pokorski RJ.
    J Insur Med; 2002; 34(1):43-60. PubMed ID: 15303593
    [Abstract] [Full Text] [Related]

  • 22. Relation of 12-lead electrocardiogram patterns to implanted defibrillator-terminated ventricular tachyarrhythmias in hypertrophic cardiomyopathy.
    Sherrid MV, Cotiga D, Hart D, Ehlert F, Haas TS, Shen WK, Link MS, Estes NA, Epstein AE, Semsarian C, Daubert JP, Winters SL, Giudici MC, Maron BJ.
    Am J Cardiol; 2009 Dec 15; 104(12):1722-6. PubMed ID: 19962483
    [Abstract] [Full Text] [Related]

  • 23. Syncope, other risk factors, and the implantable defibrillator for sudden death prevention in hypertrophic cardiomyopathy.
    Cotiga D, Ehlert F, Sherrid M.
    Anadolu Kardiyol Derg; 2006 Dec 15; 6 Suppl 2():55-60. PubMed ID: 17162272
    [Abstract] [Full Text] [Related]

  • 24. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: patient outcomes, rate of appropriate and inappropriate interventions, and complications.
    Vriesendorp PA, Schinkel AF, Van Cleemput J, Willems R, Jordaens LJ, Theuns DA, van Slegtenhorst MA, de Ravel TJ, ten Cate FJ, Michels M.
    Am Heart J; 2013 Sep 15; 166(3):496-502. PubMed ID: 24016499
    [Abstract] [Full Text] [Related]

  • 25. Obesity as a risk factor for sustained ventricular tachyarrhythmias in MADIT II patients.
    Pietrasik G, Goldenberg I, McNitt S, Moss AJ, Zareba W.
    J Cardiovasc Electrophysiol; 2007 Feb 15; 18(2):181-4. PubMed ID: 17338766
    [Abstract] [Full Text] [Related]

  • 26. The Italian Implantable Cardioverter-Defibrillator Registry. A survey of the national activity during the years 2001-2003.
    Proclemer A, Ghidina M, Cicuttini G, Gregori D, Fioretti PM.
    Ital Heart J; 2005 Mar 15; 6(3):272-80. PubMed ID: 15875520
    [Abstract] [Full Text] [Related]

  • 27. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.
    Rolf S, Haverkamp W, Borggrefe M, Breithardt G, Bocker D.
    Europace; 2009 Mar 15; 11(3):289-96. PubMed ID: 19095687
    [Abstract] [Full Text] [Related]

  • 28. [Use of an implantable defibrillator for the prevention of sudden death in hypertrophic cardiomyopathy].
    Hentati M, Ben Ameur I, Kechida Z, Charfeddine H, Hached L, Grati Z, Kammoun S.
    Tunis Med; 2003 Mar 15; 81 Suppl 8():675-9. PubMed ID: 14608758
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
    Wichter T, Paul TM, Eckardt L, Gerdes P, Kirchhof P, Böcker D, Breithardt G.
    Herz; 2005 Mar 15; 30(2):91-101. PubMed ID: 15875097
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death.
    Cuculich PS, Sánchez JM, Kerzner R, Greenberg SL, Sengupta J, Chen J, Faddis MN, Gleva MJ, Smith TW, Lindsay BD.
    Pacing Clin Electrophysiol; 2007 Feb 15; 30(2):207-13. PubMed ID: 17338717
    [Abstract] [Full Text] [Related]

  • 34. The relation of ventricular arrhythmia electrophysiological characteristics to cardiac phenotype and circadian patterns in hypertrophic cardiomyopathy.
    O'Mahony C, Lambiase PD, Rahman SM, Cardona M, Calcagnino M, Quarta G, Tsovolas K, Al-Shaikh S, McKenna W, Elliott P.
    Europace; 2012 May 15; 14(5):724-33. PubMed ID: 22094454
    [Abstract] [Full Text] [Related]

  • 35. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy.
    Huang DT, Sesselberg HW, McNitt S, Noyes K, Andrews ML, Hall WJ, Dick A, Daubert JP, Zareba W, Moss AJ, MADIT-II Research Group.
    J Cardiovasc Electrophysiol; 2007 Aug 15; 18(8):833-8. PubMed ID: 17537209
    [Abstract] [Full Text] [Related]

  • 36. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
    Adabag AS, Casey SA, Kuskowski MA, Zenovich AG, Maron BJ.
    J Am Coll Cardiol; 2005 Mar 01; 45(5):697-704. PubMed ID: 15734613
    [Abstract] [Full Text] [Related]

  • 37. The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy.
    Zecchin M, Di Lenarda A, Proclemer A, Faganello G, Facchin D, Petz E, Sinagra G.
    Europace; 2004 Sep 01; 6(5):400-6. PubMed ID: 15294264
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Rates and predictors of appropriate implantable cardioverter-defibrillator therapy delivery: results from the EVADEF cohort study.
    Otmani A, Trinquart L, Marijon E, Lavergne T, Waintraub X, Lepillier A, Chatellier G, Le Heuzey JY, EVADEF investigators.
    Am Heart J; 2009 Aug 01; 158(2):230-237.e1. PubMed ID: 19619699
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.